SKP2 Human (-)-demecolcine decreases expression EXP 6480464 Demecolcine results in decreased expression of SKP2 mRNA CTD PMID:23649840 SKP2 Human (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SKP2 mRNA CTD PMID:22079256 SKP2 Human 1-chloro-2,4-dinitrobenzene increases expression ISO Skp2 (Mus musculus) 6480464 Dinitrochlorobenzene results in increased expression of SKP2 mRNA CTD PMID:21404309 SKP2 Human 17alpha-ethynylestradiol multiple interactions ISO Skp2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SKP2 mRNA CTD PMID:17942748 SKP2 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SKP2 mRNA more ... CTD PMID:23029392 and PMID:30165855 SKP2 Human 17beta-estradiol increases expression ISO Skp2 (Rattus norvegicus) 6480464 Estradiol results in increased expression of SKP2 mRNA CTD PMID:32145629 SKP2 Human 17beta-estradiol increases response to substance EXP 6480464 SKP2 protein results in increased susceptibility to Estradiol CTD PMID:23029392 SKP2 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SKP2 protein CTD PMID:23029392 SKP2 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Skp2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SKP2 mRNA CTD PMID:17942748 SKP2 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Skp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SKP2 mRNA CTD PMID:21570461 SKP2 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SKP2 mRNA CTD PMID:20106945 and PMID:21632981 SKP2 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Skp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SKP2 mRNA CTD PMID:19465110 SKP2 Human 2-butoxyethanol increases expression ISO Skp2 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of SKP2 mRNA CTD PMID:19812364 SKP2 Human 2-methylcholine affects expression EXP 6480464 beta-methylcholine affects the expression of SKP2 mRNA CTD PMID:21179406 SKP2 Human 2-palmitoylglycerol increases expression EXP 6480464 2-palmitoylglycerol results in increased expression of SKP2 mRNA CTD PMID:37199045 SKP2 Human 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of SKP2 mRNA CTD PMID:25912373 SKP2 Human 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO Skp2 (Mus musculus) 6480464 Oxazolone results in increased expression of SKP2 mRNA CTD PMID:21404309 SKP2 Human 4-nitrophenol decreases expression ISO Skp2 (Mus musculus) 6480464 4-nitrophenol results in decreased expression of SKP2 mRNA CTD PMID:34673133 SKP2 Human acetamide increases expression ISO Skp2 (Rattus norvegicus) 6480464 acetamide results in increased expression of SKP2 mRNA CTD PMID:31881176 SKP2 Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of SKP2 mRNA CTD PMID:21632981 and PMID:21641981 SKP2 Human aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of SKP2 gene CTD PMID:27153756 SKP2 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of SKP2 mRNA and Tretinoin results in decreased expression of SKP2 protein CTD PMID:15498508 more ... SKP2 Human all-trans-retinoic acid multiple interactions EXP 6480464 [Tretinoin results in increased ubiquitination of and results in increased degradation of SKP2 protein] which results in increased expression of CDKN1B protein and Tretinoin results in increased ubiquitination of and results in increased degradation of SKP2 protein CTD PMID:11595732 SKP2 Human all-trans-retinoic acid decreases response to substance EXP 6480464 SKP2 protein results in decreased susceptibility to Tretinoin CTD PMID:11595732 SKP2 Human arachidonic acid decreases expression EXP 6480464 Arachidonic Acid results in decreased expression of SKP2 mRNA CTD PMID:16704987 SKP2 Human aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of SKP2 mRNA CTD PMID:33212167 SKP2 Human arsane affects methylation EXP 6480464 Arsenic affects the methylation of SKP2 gene CTD PMID:25304211 SKP2 Human arsane decreases expression EXP 6480464 Arsenic results in decreased expression of SKP2 mRNA CTD PMID:29248574 SKP2 Human arsane multiple interactions EXP 6480464 UCA1 mRNA promotes the reaction [Arsenic results in decreased expression of SKP2 protein] CTD PMID:29248574 SKP2 Human arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of SKP2 gene CTD PMID:25304211 SKP2 Human arsenic atom multiple interactions EXP 6480464 UCA1 mRNA promotes the reaction [Arsenic results in decreased expression of SKP2 protein] CTD PMID:29248574 SKP2 Human arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of SKP2 mRNA CTD PMID:29248574 SKP2 Human arsenite(3-) affects expression EXP 6480464 arsenite affects the expression of SKP2 mRNA CTD PMID:22959463 SKP2 Human arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of SKP2 protein CTD PMID:25174355 and PMID:25335113 SKP2 Human arsenous acid increases expression ISO Skp2 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of SKP2 mRNA CTD PMID:29095437 SKP2 Human arsenous acid multiple interactions ISO Skp2 (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of SKP2 mRNA] CTD PMID:29095437 SKP2 Human atrazine increases expression ISO Skp2 (Mus musculus) 6480464 Atrazine results in increased expression of SKP2 protein CTD PMID:33766575 SKP2 Human azathioprine decreases expression EXP 6480464 Azathioprine results in decreased expression of SKP2 mRNA CTD PMID:22623647 SKP2 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of SKP2 mRNA CTD PMID:20106945 more ... SKP2 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of SKP2 mRNA CTD PMID:33411230 SKP2 Human benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:20382639 SKP2 Human bis(2-chloroethyl) sulfide decreases expression EXP 6480464 Mustard Gas results in decreased expression of SKP2 mRNA CTD PMID:25102026 SKP2 Human bisphenol A decreases expression ISO Skp2 (Mus musculus) 6480464 bisphenol A results in decreased expression of SKP2 mRNA CTD PMID:25270620 and PMID:26063408 SKP2 Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SKP2 mRNA CTD PMID:30903817 SKP2 Human bisphenol A decreases expression ISO Skp2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of SKP2 mRNA CTD PMID:25181051 more ... SKP2 Human bortezomib decreases expression EXP 6480464 Bortezomib results in decreased expression of SKP2 protein CTD PMID:18850583 and PMID:19636294 SKP2 Human bortezomib multiple interactions EXP 6480464 Cisplatin promotes the reaction [Bortezomib results in decreased expression of SKP2 protein] CTD PMID:19636294 SKP2 Human C60 fullerene decreases expression ISO Skp2 (Rattus norvegicus) 6480464 fullerene C60 results in decreased expression of SKP2 mRNA CTD PMID:19167457 SKP2 Human cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of SKP2 mRNA CTD PMID:21120746 SKP2 Human cadmium dichloride increases expression ISO Skp2 (Mus musculus) 6480464 Cadmium Chloride results in increased expression of SKP2 mRNA CTD PMID:20061341 SKP2 Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SKP2 mRNA CTD PMID:26472689 SKP2 Human cadmium dichloride increases methylation ISO Skp2 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased methylation of SKP2 promoter CTD PMID:22457795 SKP2 Human caffeine decreases phosphorylation EXP 6480464 Caffeine results in decreased phosphorylation of SKP2 protein CTD PMID:35688186 SKP2 Human calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of SKP2 mRNA and Calcitriol results in decreased expression of SKP2 protein CTD PMID:12954644 and PMID:21592394 SKP2 Human calcitriol multiple interactions EXP 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SKP2 mRNA CTD PMID:21592394 SKP2 Human calycosin decreases expression EXP 6480464 7 and 3'-dihydroxy-4'-methoxyisoflavone results in decreased expression of SKP2 mRNA CTD PMID:24455688 SKP2 Human cannabidiol decreases expression EXP 6480464 Cannabidiol results in decreased expression of SKP2 mRNA CTD PMID:33244087 and PMID:36519830 SKP2 Human carbon nanotube increases expression ISO Skp2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 SKP2 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to SKP2 gene] CTD PMID:28238834 SKP2 Human chlorpyrifos decreases expression ISO Skp2 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of SKP2 mRNA CTD PMID:20350560 and PMID:37019170 SKP2 Human cisplatin multiple interactions EXP 6480464 Cisplatin promotes the reaction [Bortezomib results in decreased expression of SKP2 protein] CTD PMID:19636294 SKP2 Human cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of SKP2 mRNA CTD PMID:19320972 and PMID:19376846 SKP2 Human copper atom increases expression ISO Skp2 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of SKP2 mRNA CTD PMID:26033743 SKP2 Human copper atom multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in decreased expression of SKP2 mRNA and [NSC 689534 binds to Copper] which results in decreased expression of SKP2 mRNA CTD PMID:20971185 and PMID:30911355 SKP2 Human copper(0) increases expression ISO Skp2 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of SKP2 mRNA CTD PMID:26033743 SKP2 Human copper(0) multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in decreased expression of SKP2 mRNA and [NSC 689534 binds to Copper] which results in decreased expression of SKP2 mRNA CTD PMID:20971185 and PMID:30911355 SKP2 Human copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of SKP2 mRNA CTD PMID:19549813 SKP2 Human coumarin affects phosphorylation EXP 6480464 coumarin affects the phosphorylation of SKP2 protein CTD PMID:35688186 SKP2 Human coumestrol increases expression EXP 6480464 Coumestrol results in increased expression of SKP2 mRNA CTD PMID:19167446 SKP2 Human coumestrol multiple interactions EXP 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 SKP2 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of SKP2 mRNA CTD PMID:20106945 more ... SKP2 Human DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of SKP2 mRNA CTD PMID:38568856 SKP2 Human diarsenic trioxide increases expression ISO Skp2 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of SKP2 mRNA CTD PMID:29095437 SKP2 Human diarsenic trioxide multiple interactions ISO Skp2 (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of SKP2 mRNA] CTD PMID:29095437 SKP2 Human diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of SKP2 protein CTD PMID:25174355 and PMID:25335113 SKP2 Human dibutyl phthalate decreases expression ISO Skp2 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of SKP2 mRNA CTD PMID:21266533 SKP2 Human Didecyldimethylammonium decreases expression EXP 6480464 didecyldimethylammonium results in decreased expression of SKP2 mRNA CTD PMID:32763356 SKP2 Human diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of SKP2 mRNA CTD PMID:36621641 SKP2 Human dimethylarsinous acid increases expression EXP 6480464 dimethylarsinous acid results in increased expression of SKP2 mRNA CTD PMID:19945496 SKP2 Human dioxygen decreases expression EXP 6480464 Oxygen results in decreased expression of SKP2 mRNA CTD PMID:27103661 SKP2 Human diuron decreases expression EXP 6480464 Diuron results in decreased expression of SKP2 mRNA CTD PMID:35967413 SKP2 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SKP2 Human doxorubicin affects expression EXP 6480464 Doxorubicin affects the expression of SKP2 mRNA and Doxorubicin affects the expression of SKP2 protein CTD PMID:17893511 SKP2 Human doxorubicin affects response to substance EXP 6480464 SKP2 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 SKP2 Human endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SKP2 mRNA CTD PMID:30090376 SKP2 Human Enterolactone multiple interactions EXP 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKP2 mRNA CTD PMID:19167446 SKP2 Human folic acid multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of SKP2 mRNA CTD PMID:24657277 SKP2 Human formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of SKP2 mRNA CTD PMID:20655997 and PMID:23649840 SKP2 Human FR900359 decreases phosphorylation EXP 6480464 FR900359 results in decreased phosphorylation of SKP2 protein CTD PMID:37730182 SKP2 Human fraxetin decreases expression EXP 125097526 Fraxetin decreases expression of SKP2 mRNA and protein in colorectum RGD SKP2 Human gamma-linolenic acid decreases expression EXP 6480464 gamma-Linolenic Acid results in decreased expression of SKP2 mRNA CTD PMID:20664735 SKP2 Human geraniol decreases expression EXP 6480464 geraniol results in decreased expression of SKP2 mRNA CTD PMID:27683099 SKP2 Human glyphosate decreases expression EXP 6480464 Glyphosate results in decreased expression of SKP2 mRNA CTD PMID:31295307 SKP2 Human GW 3965 decreases expression EXP 6480464 GW 3965 results in decreased expression of SKP2 mRNA CTD PMID:31437187 SKP2 Human GW 4064 increases expression EXP 6480464 GW 4064 results in increased expression of SKP2 mRNA CTD PMID:31437187 SKP2 Human irinotecan increases response to substance EXP 6480464 SKP2 protein results in increased susceptibility to Irinotecan CTD PMID:16734730 SKP2 Human isosilybin A decreases expression EXP 6480464 isosilybin A results in decreased expression of SKP2 protein CTD PMID:18435416 SKP2 Human lactacystin multiple interactions EXP 6480464 lactacystin inhibits the reaction [Estradiol results in increased expression of SKP2 protein] CTD PMID:23029392 SKP2 Human lactacystin decreases expression EXP 6480464 lactacystin results in decreased expression of SKP2 protein CTD PMID:23029392 SKP2 Human leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of SKP2 mRNA CTD PMID:28988120 SKP2 Human maneb multiple interactions ISO Skp2 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in increased expression of SKP2 mRNA CTD PMID:36117858 SKP2 Human metformin multiple interactions ISO Skp2 (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of SKP2 mRNA] CTD PMID:29095437 SKP2 Human methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of SKP2 mRNA CTD PMID:24657277 SKP2 Human methotrexate multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of SKP2 mRNA CTD PMID:24657277 SKP2 Human methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of SKP2 mRNA CTD PMID:28001369 SKP2 Human mono(2-ethylhexyl) phthalate multiple interactions ISO Skp2 (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of SKP2 mRNA CTD PMID:31884101 SKP2 Human monobenzyl phthalate multiple interactions ISO Skp2 (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of SKP2 mRNA CTD PMID:31884101 SKP2 Human monoethyl phthalate multiple interactions ISO Skp2 (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of SKP2 mRNA CTD PMID:31884101 SKP2 Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO Skp2 (Mus musculus) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SKP2 mRNA CTD PMID:20061341 SKP2 Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [SKP2 protein results in decreased expression of DUSP1 protein] CTD PMID:34697729 SKP2 Human nickel atom multiple interactions ISO Skp2 (Mus musculus) 6480464 MT1 affects the reaction [Nickel affects the expression of SKP2 mRNA] and MT2 affects the reaction [Nickel affects the expression of SKP2 mRNA] CTD PMID:16166738 SKP2 Human nickel dichloride decreases expression EXP 6480464 nickel chloride results in decreased expression of SKP2 mRNA CTD PMID:17312168 SKP2 Human nitrofen decreases expression ISO Skp2 (Rattus norvegicus) 6480464 nitrofen results in decreased expression of SKP2 mRNA CTD PMID:33484710 SKP2 Human orlistat decreases expression EXP 6480464 orlistat results in decreased expression of SKP2 protein CTD PMID:15138278 SKP2 Human orlistat multiple interactions EXP 6480464 [orlistat results in decreased activity of FASN protein] which results in decreased expression of SKP2 protein CTD PMID:15138278 SKP2 Human oxaliplatin decreases expression ISO Skp2 (Rattus norvegicus) 6480464 oxaliplatin results in decreased expression of SKP2 mRNA CTD PMID:25729387 SKP2 Human oxaliplatin multiple interactions ISO Skp2 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SKP2 mRNA CTD PMID:25729387 SKP2 Human ozone multiple interactions ISO Skp2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SKP2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SKP2 mRNA CTD PMID:34911549 SKP2 Human paclitaxel affects response to substance EXP 6480464 SKP2 protein affects the susceptibility to Paclitaxel CTD PMID:16217747 SKP2 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SKP2 mRNA CTD PMID:21420995 SKP2 Human paraquat multiple interactions ISO Skp2 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in increased expression of SKP2 mRNA CTD PMID:36117858 SKP2 Human perfluorononanoic acid decreases expression EXP 6480464 perfluoro-n-nonanoic acid results in decreased expression of SKP2 mRNA CTD PMID:32588087 SKP2 Human phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of SKP2 mRNA CTD PMID:26678675 SKP2 Human phenobarbital affects expression ISO Skp2 (Mus musculus) 6480464 Phenobarbital affects the expression of SKP2 mRNA CTD PMID:23091169 SKP2 Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SKP2 mRNA CTD PMID:27188386 SKP2 Human piroxicam decreases expression EXP 6480464 Piroxicam results in decreased expression of SKP2 mRNA CTD PMID:21858171 SKP2 Human potassium chromate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SKP2 mRNA CTD PMID:22079256 SKP2 Human potassium chromate decreases expression EXP 6480464 potassium chromate(VI) results in decreased expression of SKP2 mRNA CTD PMID:22079256 SKP2 Human potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of SKP2 protein CTD PMID:23718831 SKP2 Human potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of SKP2 protein CTD PMID:23718831 SKP2 Human pregnenolone 16alpha-carbonitrile multiple interactions ISO Skp2 (Mus musculus) 6480464 [1 more ... CTD PMID:23626729 SKP2 Human progesterone multiple interactions EXP 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of SKP2 protein CTD PMID:23029392 SKP2 Human quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of SKP2 mRNA CTD PMID:21632981 and PMID:23727915 SKP2 Human raloxifene decreases expression EXP 6480464 Raloxifene Hydrochloride results in decreased expression of SKP2 mRNA CTD PMID:22965848 SKP2 Human resveratrol multiple interactions EXP 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of SKP2 mRNA CTD PMID:19167446 SKP2 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SKP2 Human silibinin decreases expression EXP 6480464 Silybin results in decreased expression of SKP2 protein CTD PMID:18435416 SKP2 Human silver(1+) nitrate increases expression EXP 6480464 Silver Nitrate analog results in increased expression of SKP2 mRNA CTD PMID:22831968 SKP2 Human sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of SKP2 protein CTD PMID:21092744 SKP2 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of SKP2 mRNA CTD PMID:28595984 and PMID:34032870 SKP2 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of SKP2 mRNA CTD PMID:23876855 and PMID:38568856 SKP2 Human sodium dichromate affects expression ISO Skp2 (Rattus norvegicus) 6480464 sodium bichromate affects the expression of SKP2 mRNA CTD PMID:22110744 SKP2 Human sodium tungstate increases expression EXP 6480464 sodium tungstate(VI) results in increased expression of SKP2 mRNA CTD PMID:26164860 SKP2 Human stattic multiple interactions ISO Skp2 (Rattus norvegicus) 6480464 stattic inhibits the reaction [EDN1 protein results in increased expression of SKP2 mRNA] and stattic inhibits the reaction [EDN1 protein results in increased expression of SKP2 protein] CTD PMID:30670587 SKP2 Human sulindac sulfide decreases expression EXP 6480464 sulindac sulfide results in decreased expression of SKP2 mRNA CTD PMID:16184548 SKP2 Human sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of SKP2 mRNA CTD PMID:31533062 SKP2 Human tamibarotene decreases expression EXP 6480464 tamibarotene results in decreased expression of SKP2 mRNA CTD PMID:15498508 SKP2 Human tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of SKP2 mRNA CTD PMID:15336504 SKP2 Human tert-butyl hydroperoxide decreases methylation EXP 6480464 tert-Butylhydroperoxide results in decreased methylation of SKP2 intron CTD PMID:29432895 SKP2 Human testosterone multiple interactions EXP 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SKP2 mRNA CTD PMID:21592394 SKP2 Human testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of SKP2 mRNA CTD PMID:21592394 SKP2 Human tetrachloromethane increases expression ISO Skp2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of SKP2 mRNA CTD PMID:31919559 SKP2 Human thiram decreases expression EXP 6480464 Thiram results in decreased expression of SKP2 mRNA CTD PMID:38568856 SKP2 Human titanium dioxide decreases expression ISO Skp2 (Mus musculus) 6480464 titanium dioxide results in decreased expression of SKP2 mRNA CTD PMID:29264374 SKP2 Human toluene 2,4-diisocyanate increases expression ISO Skp2 (Mus musculus) 6480464 Toluene 2 and 4-Diisocyanate results in increased expression of SKP2 mRNA CTD PMID:21404309 SKP2 Human topotecan multiple interactions ISO Skp2 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SKP2 mRNA CTD PMID:25729387 SKP2 Human topotecan affects response to substance EXP 6480464 SKP2 protein affects the susceptibility to Topotecan CTD PMID:16217747 SKP2 Human triacsin C decreases expression EXP 6480464 triacsin C results in decreased expression of SKP2 mRNA CTD PMID:16704987 SKP2 Human Tributyltin oxide decreases expression ISO Skp2 (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in decreased expression of SKP2 mRNA CTD PMID:18958704 and PMID:25270620 SKP2 Human trimellitic anhydride increases expression ISO Skp2 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of SKP2 mRNA CTD PMID:19042947 SKP2 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of SKP2 mRNA CTD PMID:37042841 SKP2 Human troglitazone decreases response to substance EXP 6480464 SKP2 protein results in decreased susceptibility to troglitazone CTD PMID:12717389 SKP2 Human troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of SKP2 mRNA and troglitazone results in decreased expression of SKP2 protein CTD PMID:12717389 more ... SKP2 Human tungsten increases expression ISO Skp2 (Mus musculus) 6480464 Tungsten results in increased expression of SKP2 mRNA CTD PMID:30912803 SKP2 Human urethane decreases expression EXP 6480464 Urethane results in decreased expression of SKP2 mRNA CTD PMID:28818685 SKP2 Human valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of SKP2 gene CTD PMID:29154799 SKP2 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SKP2 mRNA CTD PMID:27188386 SKP2 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SKP2 mRNA CTD PMID:23179753 more ... SKP2 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of SKP2 mRNA CTD PMID:25979313 SKP2 Human vincaleukoblastine affects response to substance EXP 6480464 SKP2 protein affects the susceptibility to Vinblastine CTD PMID:16217747 SKP2 Human vincristine decreases expression EXP 6480464 Vincristine results in decreased expression of SKP2 mRNA CTD PMID:23649840
